Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study

Table 2 Association between the admission 2OG levels and short-term outcomes

	OR (95% CI)	p	Per-SD increase	p
Unadjusted	2.2 (1.3, 3.7)	0.003	1.4 (1.1, 1.8)	0.001
Adjusted model 1	2.1 (1.2, 3.6)	0.012	1.4 (1.1, 1.8)	0.004
Adjusted model 2	1.9 (1.1, 3.4)	0.032	1.4 (1.1, 1.7)	0.018

Model 1: adjusted for age, sex, BMI, current smoking, LDL-C, AF, DM and hypertension; model 2: adjusted for model 1 plus NT-proBNP levels, eGFR, and medications (including ACEIs/ARBs, beta-blockers)
Abbreviations: 2OG 2-Oxoglutarate, BMI body mass index, LDL-C low-density lipoprotein cholesterol, AF Atrial fibrillation, DM Diabetes mellitus, NT-proBNP N-terminal pro B-type natriuretic peptide, eGFR estimated glomerular filtration rate, ACEIs/ARBs angiotensin-converting enzyme inhibitors/angiotensin receptor blockers

ISSN: 1528-3658